TY  - GEN
AU  - Groves,M D
AU  - Maor,M H
AU  - Meyers,C
AU  - Kyritsis,A P
AU  - Jaeckle,K A
AU  - Yung,W K
AU  - Sawaya,R E
AU  - Hess,K
AU  - Bruner,J M
AU  - Peterson,P
AU  - Levin,V A
TI  - A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme
SN  - 0360-3016
PY  - 1999///0920
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Bromodeoxyuridine
KW  - Cognition
KW  - drug effects
KW  - Combined Modality Therapy
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Glioblastoma
KW  - Humans
KW  - Lomustine
KW  - Male
KW  - Middle Aged
KW  - Procarbazine
KW  - Radiation-Sensitizing Agents
KW  - Reoperation
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1016/s0360-3016(99)00122-4
ER  -